Beghetti M - Search Results

1

Riociguat for pulmonary arterial hypertension associated with congenital heart disease.

Rosenkranz S, Ghofrani HA, Beghetti M, Ivy D, Frey R, Fritsch A, Weimann G, Saleh S, Apitz C. Rosenkranz S, et al. Among authors: beghetti m. Heart. 2015 Nov;101(22):1792-9. doi: 10.1136/heartjnl-2015-307832. Epub 2015 Jul 1. Heart. 2015. PMID: 26135803 Free PMC article. Clinical Trial.

2

Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients.

Beghetti M, Habre W, Friedli B, Berner M. Beghetti M, et al. Br Heart J. 1995 Jan;73(1):65-8. doi: 10.1136/hrt.73.1.65. Br Heart J. 1995. PMID: 7888265 Free PMC article.

3

Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease.

Berner M, Beghetti M, Spahr-Schopfer I, Oberhansli I, Friedli B. Berner M, et al. Among authors: beghetti m. Am J Cardiol. 1996 Mar 1;77(7):532-5. doi: 10.1016/s0002-9149(97)89353-8. Am J Cardiol. 1996. PMID: 8629600

4

Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.

Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M. Rimensberger PC, et al. Among authors: beghetti m. Circulation. 2001 Jan 30;103(4):544-8. doi: 10.1161/01.cir.103.4.544. Circulation. 2001. PMID: 11157720 Clinical Trial.

5

Long term inhalation of iloprost in a child with primary pulmonary hypertension: an alternative to continuous infusion.

Beghetti M, Berner M, Rimensberger PC. Beghetti M, et al. Heart. 2001 Sep;86(3):E10. doi: 10.1136/heart.86.3.e10. Heart. 2001. PMID: 11514501 Free PMC article.

6

Congenital heart disease and pulmonary hypertension.

Beghetti M. Beghetti M. Rev Port Cardiol. 2004 Feb;23(2):273-81. Rev Port Cardiol. 2004. PMID: 15116461 Review. No abstract available.

7

Endothelin-1 in congenital heart disease.

Beghetti M, Black SM, Fineman JR. Beghetti M, et al. Pediatr Res. 2005 May;57(5 Pt 2):16R-20R. doi: 10.1203/01.PDR.0000160447.83332.13. Epub 2005 Apr 6. Pediatr Res. 2005. PMID: 15817494 Review.

8

Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.

Ivy DD, Doran AK, Smith KJ, Mallory GB Jr, Beghetti M, Barst RJ, Brady D, Law Y, Parker D, Claussen L, Abman SH. Ivy DD, et al. Among authors: beghetti m. J Am Coll Cardiol. 2008 Jan 15;51(2):161-9. doi: 10.1016/j.jacc.2007.09.031. J Am Coll Cardiol. 2008. PMID: 18191742 Free PMC article.

9

Review of inhaled iloprost for the control of pulmonary artery hypertension in children.

Tissot C, Beghetti M. Tissot C, et al. Among authors: beghetti m. Vasc Health Risk Manag. 2009;5(1):325-31. doi: 10.2147/vhrm.s3222. Epub 2009 Apr 8. Vasc Health Risk Manag. 2009. PMID: 19436672 Free PMC article. Review.

10

Pulmonary arterial hypertension in congenital heart diseases.

Beghetti M, Tissot C. Beghetti M, et al. Semin Respir Crit Care Med. 2009 Aug;30(4):421-8. doi: 10.1055/s-0029-1233311. Epub 2009 Jul 24. Semin Respir Crit Care Med. 2009. PMID: 19634081 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters